Dr Beth Johnson's research is focused on reducing barriers to care and improving the diagnostic process for neurodivergent children, with a particular interst in autism and attention deficit hyperactivity disorder (ADHD). 

Their research is using data-driven methods to uncover new, objective markers that outperform current diagnostic practices in terms of predicting prognosis, and therapeutic outcomes for children who may require additional support. To better understand trans-diagnostic needs that span across traditional diagnostic boundaries, their resarch uses multi-dimensional phenotyping (behavioural, neurocognitive, environment), alongside genetics, to capture the breadth of neurodevelopmental traits and identify areas of support, in consultation and collaboration with neurodivergent communities to ensure community-prioritised outcomes are met.

Dr Johnson is passionate is developing a range of methods to improve engagement of families in community-led research priorities, such as streamlining and harmonise high-quality data collection from across public health services, to reduce burden and ensure a broader and more appropriate representation of the neurodivergent community in research datasets, through to using VR and digital technologies to reduce anxiety when attending appointments in hospital settings.